MedTrace Logo

Screening of Valvular Heart Disease Using Single-channel Electrocardiogram

NCT07099417 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2025-08-01

No results posted yet for this study

Summary

It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 1000 patients over 18 years old in the training sample and 200 patients over 18 years old in the test sample (the total number of patients is at least 1200 people).

All patients will undergo an echocardiography examination with a comprehensive analysis of the function of the valves and other structures of the heart according to current recommendations by two independent experts.

Registration of electrocardiogram will be performed immediately after echocardiography using a single lead ECG monitor (in I standard lead) for 1 minutes.

The obtained data will be stored in the remote monitoring center of Sechenov University without being linked to the personal data of patients.

A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform.

The result of this study will be the identification of ECG parameters that will correlate with valvular heart disease.

Conditions

  • Valvular Heart Disease Stenosis and Regurgitation
  • Valvular Heart Disease

Interventions

DIAGNOSTIC_TEST

No intervention (observational study)

No intervention (observational study)

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Philipp Kopylov, Prof. · I.M. Sechenov First Moscow State Medical University (Sechenov University)

  • Natalia Kuznetsova, Dr. · I.M. Sechenov First Moscow State Medical University (Sechenov University)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07099417 on ClinicalTrials.gov